PrEP

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (HIV PEP) Pre-Exposure Prophylaxis (HIV PrEP) for the prevention of HIV acquisition in British Columbia What’s New in the Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia (BC) […]

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Read More »

Increased use of and confidence in antiretroviral PrEP for prevention of HIV found

By

More gay and bisexual men are using HIV pre-exposure prophylaxis (PrEP) with increased confidence in the benefits of HIV treatment for prevention, according to a UNSW study. Significantly more gay and bisexual men are using the antiretroviral drug PrEP to prevent HIV infection, according to the latest report from the PrEPARE Project. The national online

Increased use of and confidence in antiretroviral PrEP for prevention of HIV found Read More »

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible

By

Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search